Prolonged Hyperoxygenation Treatment Improves Vein Graft Patency and Decreases Macrophage Content in Atherosclerotic Lesions in ApoE3*Leiden Mice.
Animals
Apolipoprotein E3
/ metabolism
Apoptosis
/ drug effects
Atherosclerosis
/ complications
Blood Vessel Prosthesis
Carbon Dioxide
/ pharmacology
DNA Damage
Hemorrhage
/ complications
Hypoxia
/ complications
Inflammation
/ complications
Macrophages
/ drug effects
Male
Mice, Inbred C57BL
Myocytes, Smooth Muscle
/ drug effects
Neovascularization, Pathologic
/ pathology
Oxygen
/ pharmacology
Plaque, Atherosclerotic
/ complications
Reactive Oxygen Species
/ metabolism
Vascular Patency
/ drug effects
Veins
/ drug effects
atherosclerosis
hyperoxygenation
macrophages
vascular biology
vein graft disease
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
01 02 2020
01 02 2020
Historique:
received:
20
01
2020
accepted:
30
01
2020
entrez:
7
2
2020
pubmed:
7
2
2020
medline:
11
2
2021
Statut:
epublish
Résumé
Unstable atherosclerotic plaques frequently show plaque angiogenesis which increases the chance of rupture and thrombus formation leading to infarctions. Hypoxia plays a role in angiogenesis and inflammation, two processes involved in the pathogenesis of atherosclerosis. We aim to study the effect of resolution of hypoxia using carbogen gas (95% O
Identifiants
pubmed: 32024075
pii: cells9020336
doi: 10.3390/cells9020336
pmc: PMC7072413
pii:
doi:
Substances chimiques
Apolipoprotein E3
0
Reactive Oxygen Species
0
apolipoprotein E3 (Leidein)
0
Carbon Dioxide
142M471B3J
carbogen
8063-77-2
Oxygen
S88TT14065
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Sci Rep. 2015 Jul 14;5:11427
pubmed: 26169582
Circ Res. 2014 Jun 6;114(12):1852-66
pubmed: 24902970
J Immunotoxicol. 2010 Oct-Dec;7(4):239-54
pubmed: 20586583
PLoS One. 2012;7(10):e47134
pubmed: 23071737
Int J Mol Med. 2018 Jan;41(1):322-330
pubmed: 29138796
Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):755-61
pubmed: 17272744
Am J Clin Nutr. 1993 May;57(5 Suppl):715S-724S; discussion 724S-725S
pubmed: 8475889
Mutat Res. 2004 Sep;567(1):1-61
pubmed: 15341901
Insight. 2012 Fall;37(4):10-1
pubmed: 23256429
Pharmacol Ther. 2018 Mar;183:22-33
pubmed: 28942242
Annu Rev Physiol. 1986;48:703-19
pubmed: 3010832
Ther Adv Urol. 2013 Feb;5(1):25-34
pubmed: 23372608
J Am Coll Cardiol. 2008 Apr 1;51(13):1258-65
pubmed: 18371555
Curr Opin Lipidol. 2016 Oct;27(5):499-506
pubmed: 27472406
J Mol Cell Cardiol. 2018 Aug;121:16-24
pubmed: 29879406
J Intern Med. 2019 Jan;285(1):59-74
pubmed: 30102798
Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1782-90
pubmed: 27444197
Drug Discov Today. 2016 Oct;21(10):1578-1595
pubmed: 27265770
Nat Rev Cardiol. 2016 Aug;13(8):451-70
pubmed: 27194091
J Cereb Blood Flow Metab. 2017 Jun;37(6):2270-2282
pubmed: 27496553
Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2545-53
pubmed: 25256233
J Surg Res. 2000 Jun 1;91(1):32-7
pubmed: 10816346
Med Gas Res. 2016 Oct 14;6(3):138-146
pubmed: 27867481
J Am Coll Cardiol. 2009 Apr 28;53(17):1517-27
pubmed: 19389562
J Atheroscler Thromb. 2017 Sep 1;24(9):884-894
pubmed: 28757538
Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1088-1099
pubmed: 31070451
Toxicol Res (Camb). 2018 Jul 4;7(5):970-976
pubmed: 30310674
Curr Opin Lipidol. 2013 Oct;24(5):393-400
pubmed: 23942270
Am J Physiol. 1999 Sep;277(3):L589-95
pubmed: 10484467
Curr Opin Lipidol. 2009 Oct;20(5):409-14
pubmed: 19644366
Free Radic Biol Med. 2002 Nov 1;33(9):1231-42
pubmed: 12398931
Proc Natl Acad Sci U S A. 2015 Sep 8;112(36):11389-94
pubmed: 26217001
EMBO J. 1995 Jun 15;14(12):2876-83
pubmed: 7796813
Oncol Lett. 2015 Oct;10(4):2009-2014
pubmed: 26622788
Arterioscler Thromb Vasc Biol. 2015 Jun;35(6):1463-71
pubmed: 25882065
Eur J Pharmacol. 2017 Dec 5;816:107-115
pubmed: 28435093